Correlation Between MedMira and Pharming Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MedMira and Pharming Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedMira and Pharming Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedMira and Pharming Group NV, you can compare the effects of market volatilities on MedMira and Pharming Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedMira with a short position of Pharming Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedMira and Pharming Group.

Diversification Opportunities for MedMira and Pharming Group

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between MedMira and Pharming is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding MedMira and Pharming Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharming Group NV and MedMira is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedMira are associated (or correlated) with Pharming Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharming Group NV has no effect on the direction of MedMira i.e., MedMira and Pharming Group go up and down completely randomly.

Pair Corralation between MedMira and Pharming Group

Assuming the 90 days horizon MedMira is expected to generate 1.07 times more return on investment than Pharming Group. However, MedMira is 1.07 times more volatile than Pharming Group NV. It trades about 0.08 of its potential returns per unit of risk. Pharming Group NV is currently generating about 0.01 per unit of risk. If you would invest  5.00  in MedMira on September 15, 2024 and sell it today you would earn a total of  0.50  from holding MedMira or generate 10.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.46%
ValuesDaily Returns

MedMira  vs.  Pharming Group NV

 Performance 
       Timeline  
MedMira 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MedMira are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, MedMira may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Pharming Group NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharming Group NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Pharming Group is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

MedMira and Pharming Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MedMira and Pharming Group

The main advantage of trading using opposite MedMira and Pharming Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedMira position performs unexpectedly, Pharming Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharming Group will offset losses from the drop in Pharming Group's long position.
The idea behind MedMira and Pharming Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance